Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Clinical trial NCT00242294 · COMPLETED

Trial details

NCT number: NCT00242294
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2004-11-01
Primary completion: 2006-09-01
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.